Cellares Secures New Investment to Advance Global Cell Therapy Manufacturing Infrastructure
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), announced that Prime Radiant Fund SLP SICAV-RAIF, a fund advised by Prime Radiant Partners, has made a $50 million growth equity investment in the company’s Series D financing, bringing the total Series D to $327 million. “Cell therapy…
